康丹红 高健 王永春 杨晓冬 孙盼盼.辛伐他汀治疗老年高血脂患者疗效与安全性的最佳剂量研究[J].,2015,15(31):6125-6127 |
辛伐他汀治疗老年高血脂患者疗效与安全性的最佳剂量研究 |
Efficacy and Safety of Optimal Dose of Simvastatin for Elderly Patients withHyperlipemia |
|
DOI: |
中文关键词: 高血脂症 辛伐他汀 老年 疗效 不良反应 |
英文关键词: Hyperlipemia Simvastatin Elderly Efficacy Adverse reaction |
基金项目: |
|
摘要点击次数: 652 |
全文下载次数: 0 |
中文摘要: |
目的:观察不同剂量辛伐他汀治疗老年高血脂患者疗效与安全性。方法:将纳入研究的80 例老年高血脂患者随机分为高剂
量组和低剂量组,各40 例。高剂量组给予辛伐他汀剂40 mg/ 日,低剂量组给予20 mg/日。治疗2个月后观察疗效、血脂水平变化
情况,并统计两组不良反应的发生情况。结果:高剂量组总有效率95%显著高于低剂量组的80%(P<0.05);治疗后,两组TG、TC、
LDL-C、HDL-C 水平均有改善,与本组治疗前比较均有显著性差异(P 均<0.05),且高剂量组上述指标改善明显优于低剂量组(P
均<0.05);治疗期间两组不良反应发生率无统计学意义(P>0.05)。结论:辛伐他汀高剂量(40 mg/日)治疗老年高血脂的疗效优于
低剂量(20 mg/ 日),且不增加不良反应发生的风险。 |
英文摘要: |
Objective:To observe the efficacy and safety of different doses of simvastatin in the treatment of elderly patients with
hyperlipemia.Methods:A total of 80 elderly patients with hyperlipemia were randomly divided into high dose group (n=40) and low dose
group (n=40). The high dose group was treated with 40 mg/d simvastatin, while the low dose group, 20 mg/d simvastatin. After 2 months
of treatment, the efficacy and blood lipid levels of the two groups were observed, and the incidence of adverse reactions in the two groups
was analyzed.Results:The total effective rate(95%) in the high dose group was significantly higher than that(80%) in the low dose group
(P<0.05). Compared with before treatment, the levels of TG, TC, LDL-C, HDL-C in the two groups after treatment were significantly improved(
P<0.05), and the above indexes in the high dose group were significantly better than those in the low dose group(P<0.05). There
was no significant difference in the incidence of adverse reactions between the two groups (P>0.05).Conclusion:The efficacy of high
dose of simvastatin(40mg/d) is better than that of low dose of simvastatin(20 mg/d) in the treatment of elderly patients with hyperlipemia,
which does not increase the incidence of adverse reactions. |
查看全文
查看/发表评论 下载PDF阅读器 |
关闭 |